Postoperative Care of the Cardiac Surgical Patient

  • Ross F. DiMarcoJr.


Approximately 400,000 open-heart surgeries are performed annually in the United States (1). These patients require specialized intensive care and pose unique challenges for the critical care practitioner. This chapter focuses on the pathophysiology and management of specific problems encountered postoperatively in the cardiac surgical patient.


Atrial Fibrillation Coronary Artery Bypass Grafting Myocardial Oxygen Demand Cardiac Surgical Patient Postoperative Atrial Fibrillation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lauer MS, Eagle KA, Buckley MJ, DeSanctis RW. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989; 31: 367–78.PubMedCrossRefGoogle Scholar
  2. 2.
    Cameron D. Initiation of white cell activation during cardiopulmonary bypass: cytokines and receptors. J Cardiovasc Pharmacol 1966; 27 (Suppl 1): S1–5.Google Scholar
  3. 3.
    Morris DC, St. Claire D Jr. Management of patients after cardiac surgery. Curr Probt Cardiol 1999; 24: 161–228.Google Scholar
  4. 4.
    Bojar RM. Manual of perioperative care in cardiac and thoracic surgery. 3rd ed. Boston: Blackwell Scientific, 1999.Google Scholar
  5. 5.
    Gold JP, Roberts AJ, Hoover EL, Blank S, Gay WA Jr, Subramanian VA. Effects of prolonged aortic cross-clamping with potassium cardioplegia on myocardial contractility in man. Surg Forum 1979; 30: 252–4.PubMedGoogle Scholar
  6. 6.
    Sladen RV, Berkowitz DE. Cardiopulmonary bypass and the lung. In: Gravlee, GP, Davis RF, Utley JR, eds. Cardiopulmonary bypass: principles and practice. 1st ed. Baltimore: Williams & Wilkins; 1993: 468.Google Scholar
  7. 7.
    Bolli R. Oxygen derived free radicals and postischemic myocardial dysfunction (“stunned myocardium”). J Am Coll Cardiol 1988; 12: 239–49.PubMedCrossRefGoogle Scholar
  8. 8.
    Przyklenk K, Kloner RA. “Reperfusion injury” by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res 1989; 64: 86–96.PubMedCrossRefGoogle Scholar
  9. 9.
    Spiess BD. Ischemia-a coagulation problem? J Cardiovasc Pharmacol 1996; 27 (Suppl 1): 538–41.Google Scholar
  10. 10.
    Breisblatt WM, Stein KL, Wolfe CJ, Follansbee WP, Capozzi J, Armitage JM, Hardesty RL. Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol 1990; 15: 1261–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Johnson RG, Thurer RL, Kruskall MS, Sirois C, Gervino EV, Critchlow J, Weintraub RM. Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Cardiovasc Surg 1992; 104: 307–14.PubMedGoogle Scholar
  12. 12.
    Doak GJ, Hall RI. Does hemoglobin concentration affect perioperative myocardial lactate flux in patients undergoing coronary artery bypass surgery? Anesth Analg 1995; 80: 910–6.PubMedGoogle Scholar
  13. 13.
    Ardehali A, Ports TA. Myocardial oxygen supply and demand. Chest 1990; 98: 699–705.PubMedCrossRefGoogle Scholar
  14. 14.
    Wallach R, Karp RB, Reyes JG, Oparil S, Smith LR, James TN. Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: s study of hemodynamic and humoral factors. Am J Cardiol 1980; 46: 559–65.PubMedCrossRefGoogle Scholar
  15. 15.
    Roberts AJ, Niarchos AP, Subramanian VA, Abel RM, Herman SD, Sealey JE, Case DB, White RP, Johnson GA, Laragh JH, Gay WA Jr. Systemic hypertension associated with coronary artery bypass surgery. Predisposing factors, hemodynamic characteristics, humoral profile, and treatment. J Thorac Cardiovasc Surg 1977; 74: 846–59.PubMedGoogle Scholar
  16. 16.
    Kaplan JA, Guffin AV. Perioperative management of hypertension and tachycardia. J Cardiothorac Anesth 1990; 4: 7–12.CrossRefGoogle Scholar
  17. 17.
    Fremes SE, Weisel RD, Baird RJ, Mickleborough LL, Burns RJ, Teasdale SJ, Ivanov J, Seawright SJ, Madonik MM, Mickle DA, Scully HE, Goldman BS, McLaughlin PR. Effects of postoperative hypertension and its treatment. J Thorac Cardiovasc Surg 1983; 86: 47–56.PubMedGoogle Scholar
  18. 18.
    Palmer RF, Lasseter KC. Drug therapy. Sodium nitroprusside. N Engl J Med 1975; 292: 294–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Flaherty JT, Magee PA, Gardner TL, Potter A, MacAllister NP. Comparison of intravenous nitroglycerin and sodium nitroprusside for treatment of acute hypertension developing after coronary bypass surgery. Circulation 1982; 65: 1072–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Sladen RN, Klamerus KJ, Swafford MW, Prough DS, Mann HJ, Leslie JB, Goldberg JS, Levitsky S, Molina JE, Mills SA. Labetolol for the control of elevated blood pressure following coronary artery bypass grafting. J Cardiothorac Anesth 1990; 4: 210–21.PubMedCrossRefGoogle Scholar
  21. 21.
    Boldt J, Schindler E, Wollbruck M, Gorlach G, Hempelmann G. Cardiorespiratory response of intravenous angiotensin-converting enzyme inhibitor enalaprilat in hypertensive cardiac surgery patients. J Cardiothorac Vasc Anesth 1995; 9: 44–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Bojar RM. Manual of perioperative care in cardiac and thoracic surgery. 2“ ed. Boston: Blackwell Scientific, 1994.Google Scholar
  23. 23.
    Bolli R. Oxygen-derived free radical and postischemic myocardial dysfunction (“stunned myocardium”). J Am Coll Cardiol 1988; 12: 239–49.PubMedCrossRefGoogle Scholar
  24. 24.
    Przyklenk K, Kloner RA. “Reperfusion injury” by oxygen derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res 1989; 64: 86–96.PubMedCrossRefGoogle Scholar
  25. 25.
    Bachman F, McKenna R, Cole ER, Najafi H. The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J Thorac Cardiovasc Surg 1975; 70: 76–85.Google Scholar
  26. 26.
    Casthley PA, Shah C, Mekhjian H, Swistel D, Yoganathan T, Komer C, Miguelino RA. Left ventricular diastolic function after coronary artery bypass grafting: a correlative study with three different myocardial protection techniques. J Thorac Cardiovasc Surg 1997; 114: 254–60.CrossRefGoogle Scholar
  27. 27.
    Kirklin JW, Barsatt-Boyes G. Cardiac surgery: morphology, diagnostic criteria, natural history, techniques, results, and indications. 2nd ed. New York: Churchill Livingstone, 1993.Google Scholar
  28. 28.
    Fowler MB, Alderman EL, Oesterle SN, Derby G, Daughters GT, Stinson EB, Ingels NB, Mitchell RS, Miller DC. Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine. Circulation 1984; 70: 1103–11.Google Scholar
  29. 29.
    Van Trigt P, Spray TL, Pasque MK, Peyton RB, Pellom GL, Wechsler AS. The comparative effects of dopamine and dobutamine on ventricular mechanics after coronary artery bypass grafting: a pressure-dimension analysis. Circulation 1984; 70: I112–7.PubMedGoogle Scholar
  30. 30.
    DiSesa VJ, Brown E, Mudge GH Jr, Collins JJ Jr, Cohn LH. Hemodynamic comparison of dopamine and dobutamine in the postoperative volume-loaded, pressure-loaded, and normal ventricle. J Thorac Cardiovasc Surg 1982; 83: 256–63.PubMedGoogle Scholar
  31. 31.
    Butterworth JF 4th. Use of amrinone in cardiac surgery patients. J Cardiothorac Vasc Anesth 1993; 7 (2 suppl 1): 1–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Ko W, Zelano JA, Fahey AL, Berman K, Lang D, Isom OW, Krieger KH. The effects of amrinone versus dobutamine on myocardial mechanics and energetics after hypothermic global ischemia. J Thorac Cardiovasc Surg 1993; 105: 1015–24.PubMedGoogle Scholar
  33. 33.
    Novitzky D, Cooper DK, Swanepoel A. Inotropic effect of triiodothyronine (73) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgery. Eur J Cardiothorac Surg 1989; 3: 140–5.PubMedCrossRefGoogle Scholar
  34. 34.
    Novitzky D, Cooper DK, Barton CI, Greer A, Chaffin J, Grim J, Zuhdi N. Triiodothyronine as an inotropic agent after open heart surgery. J Thorac Cardiovasc Surg 1989; 98: 972–8.PubMedGoogle Scholar
  35. 35.
    Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K. Thyroid hormone treatment after coronary-artery-bypass surgery. N Engl J Med 1995; 333: 1522–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Mullis-Jansson S, Corwin SJ, Delphin E, Jackson DT, Williams MR. A double blind placebo controlled study of the effect of triiodothyronine upon cardiac performance and outcome following coronary artery bypass surgery. (abstract) Circulation 1996; 94: I171.Google Scholar
  37. 37.
    Maccioli GA, Lucas WJ, Norfleet EA. The intraaortic balloon pump: a review. J Cardiothorac Anesth 1988; 2: 365.PubMedCrossRefGoogle Scholar
  38. 38.
    Creswell LL, Rosenbloom M, Cox JL, Ferguson TB Sr, Kouchoukos NT, Spray TL, Pasque MK, Ferguson TB Jr, Wareing TH, Huddleston CB. Intraaortic balloon counterpulsation: patterns of usage and outcome in cardiac surgery patients. Ann Thorac Surg 1992; 54: 11–20.PubMedCrossRefGoogle Scholar
  39. 39.
    Naunheim KS, Swartz MT, Pennington DG, Fiore AC, McBride LR, Peigh PS, Barnett MG, Vaca KJ, Kaiser GC, Willman VL. Intraaortic balloon pumping in patients requiring cardiac operations. Risk analysis and long-term follow-up. J Thorac Cardiovasc Surg 1992; 104: 1654–61.PubMedGoogle Scholar
  40. 40.
    Swartz MT, Sakamoto T, Arai H, Reedy JE, Salenas L, Yuda T, Standeven JW, Pennington DG. Effects of intraaortic balloon position on renal artery blood flow. Ann Thorac Surg 1992; 53: 604–10.PubMedCrossRefGoogle Scholar
  41. 41.
    Rodigas PC, Bridges KG. Occlusion of left internal mammary artery with intra-aortic balloon: clinical implications. J Thorac Cardiovasc Surg 1986; 91: 142–3.PubMedGoogle Scholar
  42. 42.
    Rohrer MJ, Sullivan CA, McLaughlin DJ, Cutler BS. A prospective randomized study comparing surgical and percutaneous removal of intraaortic balloon pump. J Thorac Cardiovasc Surg 1992; 103: 569–72.PubMedGoogle Scholar
  43. 43.
    Pennington DG, ed. Mechanical circulatory support. Semin Thorac Cardiovasc Sing 1994;6(3):129–94.Google Scholar
  44. 44.
    Argenziano M, Oz MC, Rose, EA. The continuing evolution of mechanical ventricular support. Curs Probl Surg 1997; 34: 317–86.CrossRefGoogle Scholar
  45. 45.
    Oz MC, Rose EA, Levin HR. Selection criteria for placement of left ventricular assist devices. Am Heart J 1995; 129: 173–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Chen JM, Levin HR, Rose EA, Addonizio LJ, Landry DW, Sistino JJ, Michler RE, Oz MC. Experience with right ventricular assist devices for perioperative right-sided circulatory failure. Ann Thorac Surg 1996; 61: 305–10.PubMedCrossRefGoogle Scholar
  47. 47.
    Park CH, Nishimura K, Kitano M, Matsuda K, Okamoto Y, Ban T. Analysis of right ventricular function during bypass of the left side of the heart by afterload alterations in both normal and failing hearts. J Thorac Cardiovasc Surg 1996; 111: 1092–102.PubMedCrossRefGoogle Scholar
  48. 48.
    Frazier OH. Left ventricular assist. Adv Card Surg 1997; 9: 131–48.PubMedGoogle Scholar
  49. 49.
    Dixon JF, Farris CD, Kimble Jett G. ABIOMED BVS 5000 assist device. In: Quaal SJ, ed. Cardiac mechanical assistance beyond balloon pumping. St. Louis: Mosby, 1993: 129–43.Google Scholar
  50. 50.
    Shook BJ. The ABIOMED BVS 5000 biventricular support system: system description and clinical summary. Card Surg: State Art Rev 1993; 7: 309–16.Google Scholar
  51. 51.
    Jett GK. ABIOMED BVS 5000: experience and potential advantages. Ann Thorac Surg 1996; 61: 301–4.PubMedCrossRefGoogle Scholar
  52. 52.
    Frazier OH. New technologies in the treatment of severe cardiac failure: the Texas Heart Institute experience. Ann Thorac Surg 1995; 59: S31–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Noon GP. Bio-medicus ventricular assistance. Ann Thorac Surg 1991; 52: 180–1.PubMedCrossRefGoogle Scholar
  54. 54.
    Killen DA, Piehler JM, Borkon AM, Reed WA. Bio-medicus ventricular assist device for salvage of cardiac surgical patients. Ann Thorac Surg 1991; 52: 230–5.PubMedCrossRefGoogle Scholar
  55. 55.
    Wampler RK, Moise JC, Frazier OH, Olsen DB. In vivo evaluation of a peripheral vascular access axial flow blood pump. ASAIO Trans 1988; 34: 450–4.PubMedGoogle Scholar
  56. 56.
    Wampler RK, Frazier OH, Lansing AM, Smalling RW, Nicklas JM, Phillips SJ, Guyton RA, Golding LA. Treatment of cardiogenic shock with the Hemopump left ventricular assist device. Ann Thorac Surg 1991; 52: 506–13.PubMedCrossRefGoogle Scholar
  57. 57.
    Kirklin JK, Daggett WM, Lappas DG: Postoperative care following cardiac surgery. In: Johnson RA, Haber E, Austen WG, eds. The practice of cardiology. Boston: Little Brown; 1980.:1110–32.Google Scholar
  58. 58.
    Topol EJ, Lerman BB, Baughman KL, Platia EV, Griffith LS. De novo refractory ventricular tachyarrhythmias after coronary revascularization. Am J Cardiol 1986; 57: 57–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, Collins JJ Jr, Cohn LH, Burstin HR. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996; 94: 390–7.PubMedCrossRefGoogle Scholar
  60. 60.
    Asher CR, Chung MK, Grimm RA, Arheart K, Dimengo JM, Weber MM, Cosgrove DM. Is the incidence of postoperative atrial fibrillation following cardiac valve surgery reduced by minimally invasive surgery ? (abstract). Circulation 1996; 94: I651.CrossRefGoogle Scholar
  61. 61.
    Matthew JP, Parks R, Savino JS, Friedman AS, Koch C, Mangano DT, Browner WS. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA 1996; 276: 300–6.CrossRefGoogle Scholar
  62. 62.
    Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993; 56: 539–49.PubMedCrossRefGoogle Scholar
  63. 63.
    Frost L, Molgaard H, Christiansen EH, Hjortholm K, Paulsen PK, Thomsen PE. Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials. Int J Cardiol 1992; 36: 253–61.PubMedCrossRefGoogle Scholar
  64. 64.
    Crosby LH, Pifalo WB, Woll KR, Burkholder JA. Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1990; 66: 1520–2PubMedCrossRefGoogle Scholar
  65. 65.
    Ellenbogen KA, Chung MK, Asher CR, Wood MA. Postoperative atrial fibrillation. Adv Card Surg 1997; 9: 109–30.PubMedGoogle Scholar
  66. 66.
    Leitch JW, Thomson D, Baird DK, Harris PJ. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1990; 100: 338–42.PubMedGoogle Scholar
  67. 67.
    Hashimoto K, Ilistrup DM, Schaff HV. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. J Thorac Cardiovasc Surg 1991; 101: 56–65.PubMedGoogle Scholar
  68. 68.
    Fuller JA, Adams GG, Buxton B. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly ? J Thorac Cardiovasc Surg 1989; 97: 821–5.PubMedGoogle Scholar
  69. 69.
    Matangi MF, Neutze JM, Graham KJ, Hill DG, Kerr AR, Barratt-Boyes BG. Arrhythmia prophylaxis after aorto-coronary bypass. The effect of minidose propranolol. J Thorac Cardiovasc Surg 1985; 89: 439–43.PubMedGoogle Scholar
  70. 70.
    Martinussen HJ, Lolk A, Szczepanski C, Alstrup P. Supraventricular tahyarrhythmias after coronary bypass surgery: a double blind randomized trial of prophylactic low dose propranolol. Thorac Cardiovasc Surg 1988; 36: 206–7.PubMedCrossRefGoogle Scholar
  71. 71.
    Khuri SF, Okike ON, Josa M, Vander Salm TJ, Assoussa S, Leone L, Silverman A, Siouffi S, Olukotun AY. Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting. Am J Cardiol 1987; 60: 51D - 58D.Google Scholar
  72. 72.
    Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation 1991; 84: 111236–44.Google Scholar
  73. 73.
    Kowey PR, Taylor JE, Rials SJ, Marinchak RA. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 1992; 69: 963–5.PubMedCrossRefGoogle Scholar
  74. 74.
    Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized controlled trials. Circulation 1991; 84: I11236–44.Google Scholar
  75. 75.
    Ellenbogen KA, Dias VC, Plumb VJ, Heywood JT, Mirvis DM. A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study. J Am Coll Cardiol 1991; 18: 891–7.PubMedCrossRefGoogle Scholar
  76. 76.
    Ellenbogen KA, Dias VC, Cardello FP, Strauss WE, Simonton CA, Pollak SJ, Wood MA, Stambler BS. Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter. Am J Cardiol 1995; 75: 45–9PubMedCrossRefGoogle Scholar
  77. 77.
    Friedman PI, Hoffajie CD, Reiffel JA. Practical approaches to treating atrial fibrillation. Cardiol Rev 1998; 6 (Suppl 5): 3.Google Scholar
  78. 78.
    Hjelms E. Proacainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment. Scand J Thorac Cardiovasc Surg 1992; 26: 193–6.PubMedCrossRefGoogle Scholar
  79. 79.
    Dresing, T: Tachyarrhythmias. In: Marso AP, Griffin BP, Topol EJ, eds. Manual of cardiovascular medicine. Philadelphia: Lippincott Williams and Wilkins, 2000.Google Scholar
  80. 80.
    Ellenbogan KA, Clemo HF, Stambler BS, Wood MA, VanderLugt JT. Efficacy of ibutilide for termination of atrial fibrillation and flutter. Am J Cardiol 1996; 78 (8A): 42–5.CrossRefGoogle Scholar
  81. 81.
    Pagan-Carlo LA, Spencer KT, Robertson CE, Dengler A, Birkett C, Kerber RE. Transthoracic defibrillation: importance of avoiding electrode placement directly on the female breast. J Am Coll Cardiol 1996; 27: 449–52.PubMedCrossRefGoogle Scholar
  82. 82.
    Olshansky B, Okumura K, Hess PG, Henthorn RW, Waldo AL. Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm. J Mn Coll Cardiol 1988; 11: 359–64.CrossRefGoogle Scholar
  83. 83.
    Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993; 56: 539–49.PubMedCrossRefGoogle Scholar
  84. 84.
    Reed GL 3d, Singer DE, Picard EH, DeSanctis RW. Stroke following coronary-artery-bypass surgery. A case-control estimate of the risk from carotid bruits. N Engl J Med 1988; 319: 1246–50.PubMedCrossRefGoogle Scholar
  85. 85.
    Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 1992; 19: 851–5.PubMedCrossRefGoogle Scholar
  86. 86.
    Landolfo K, Smith P. Postoperative care in cardiac surgery. In: Sabiston DC, Spencer FC, eds. Surgery of the chest. 6th ed. Philadelphia: W.B. Saunders Company 1995: 230–86.Google Scholar
  87. 87.
    Boldt J, Knothe C, Zickmann B, Bill S, Dapper F, Hempelmann G. Platelet function in cardiac surgery: influence of temperature and aprotinin. Ann Thorac Surg 1993; 55: 652–8.PubMedCrossRefGoogle Scholar
  88. 88.
    Harker LA. Bleeding after cardiopulmonary bypass. N Engl J Med 1986; 314: I446–8.CrossRefGoogle Scholar
  89. 89.
    Gravlee GP, Rogers AT, Dudas LM, Taylor R, Roy RC, Case LD, Triscott M, Brown CW, Mark LJ, Cordell AR. Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding. Anesthesiology 1992; 76: 393–401.PubMedCrossRefGoogle Scholar
  90. 91.
    Bick RL. Alterations in hemostasis associated with cardiopulmonary bypass; pathophysiology, prevention, diagnosis, and management. Semin Thromb Hemost 1976; 3: 59–82.PubMedGoogle Scholar
  91. 92.
    Stibbe J, Kluft C, Brommer EJ, Gomes M, deJong DS, Nauta J. Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator. Eur J Clin Invest 1984; 14: 375–82.PubMedCrossRefGoogle Scholar
  92. 93.
    Esters JW. Kinetics of the anticoagulant effect of heparin. JAMA 1970; 212: 1492–5.CrossRefGoogle Scholar
  93. 94.
    Schmaier AH. Diagnosis and therapy of disseminated int avascular coagulation and activated coagulation. In: Koepke JA, ed. Laboratory hematology, vol 2, New York, Churchill Livingstone,1984.Google Scholar
  94. 95.
    Goodnough LT, Johnston MF, Ramsey G, Sayers MH, Eisenstadt RS, Anderson KC, Rutman RC, Silberstein LE. Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. Transfusion Practices Committee of the American Association of Blood Banks. Ann Thorac Surg 1990; 50: 675–83.PubMedCrossRefGoogle Scholar
  95. 96.
    Wang JS, Lin Cy, Hung WT, O’Connor MF, Thisted RA, Lee BK, Karp RB, Yang MW. Thromboelastogram fails to predict postoperative hemorrhage in cardiac patients. Ann Thorac Surg 1992; 53: 435–9.PubMedCrossRefGoogle Scholar
  96. 97.
    Tuman KJ, Speiss BD, McCarthy RJ, Ivankovich AD. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Anesth Analg 1989; 69: 69–75.PubMedCrossRefGoogle Scholar
  97. 98.
    Kirsh, MM. Personal communication, 1978.Google Scholar
  98. 99.
    Vander Salm TJ, Kaur S, Lancey RA, Okike ON, Pezzella AT, Stahl RF, Leone L, Li JM, Valeri CR, Michaelson AD. Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. J Thorac Cardiovasc Surg 1996; 112: 1098–107.Google Scholar
  99. 100.
    Lemmer JH Jr, Dilling EW, Morton JR, Rich JB, Robicsek F, Bricker DL, Hantler CB, Copeland JG 3rd, Ochsner JL, Daily PO, Whitten CW, Noon GP, Maddi R. Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens. Ann Thorac Surg 1996; 62: 1659–68.PubMedCrossRefGoogle Scholar
  100. 101.
    Cicek S, Demirkilic U, Kuralay E, Ozal E, Tatar H. Postoperative aprotinin: effect on blood loss and transfusion requirements in cardiac operations. Ann Thorac Surg 1996; 61: 1372–6.PubMedCrossRefGoogle Scholar
  101. 102.
    Konishi T, Ohbayashi T, Kaneko T, Ohki T, Saitou Y, Yamato Y. Preoperative use of erythropoietin for cardiovascular operations in anemia. Ann Thorac Surg 1993; 56: 101–3.PubMedCrossRefGoogle Scholar
  102. 103.
    Johnson RG, Thurer RL, Kruskall MS, Sirois C, Gervino EV, Critchlow J, Weintraub RM. Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Cardiovasc Surg 1992; 104: 307–14.PubMedGoogle Scholar
  103. 104.
    Griffth LD, Billman GF, Daily PO, Lane TA. Apparent coagulopathy caused by infusion of shed mediastinal blood and its prevention by washing of the infusate. Ann Thorac Surg 1989; 47: 400–6.CrossRefGoogle Scholar
  104. 105.
    Axford TC, Dearani JA, Ragno G, MacGregor H, Patel MA, Valeri CR, Khuri SF. Safety and therapeutic effectiveness of reinfused shed blood after open heart surgery. Ann Thorac Surg 1994; 57: 615–22.PubMedCrossRefGoogle Scholar
  105. 106.
    Vertrees RA, Conti VR, Lick SD, Zwischenberger JB, McDaniel LB, Shulman G. Adverse effects of postoperative infusion of shed mediastinal blood. Ann Thorac Surg 1996; 62: 717–23.PubMedCrossRefGoogle Scholar
  106. 107.
    Higgins TL, Barrett C, Riden DJ, Roberts MM, Coyle JP. Influence of pleural and mediastinal chest tubes on respiration following coronary artery bypass grafting (CABG). (abstract) Chest 1989; 96 (suppl): 237S.Google Scholar
  107. 108.
    Sladden RN, Berkowitz DE. Cardiopulmonary bypass and the lung. In: Gravlee GP, Davis RF, Utley IR, eds. Cardiopulmonary bypass: principles and practice. Baltimore: Williams & Wilkins, 1993: 468.Google Scholar
  108. 109.
    Kollef MH, Schuster DP. The acute respiratory distress syndrome. N Engl J Med 1995; 332: 27–37.PubMedCrossRefGoogle Scholar
  109. 110.
    Peruzzi WT, Franklin ML, Shapiro BA. New concepts and therapies of adult respiratory distress syndrome. J Cardiothorac Vasc Anesth 1997; 11: 771–86.PubMedCrossRefGoogle Scholar
  110. 111.
    Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334–49.PubMedCrossRefGoogle Scholar
  111. 112.
    Porter GA, Kloster FE, Herr RJ, Starr A, Griswold HE, Kimsey J, Lenertz H. Relationship between alterations in renal hemodynamics during cardiopulmonary bypass and postoperative renal function. Circulation 1966; 34: 1005–21.PubMedCrossRefGoogle Scholar
  112. 113.
    Finsterbusch W, Long DM, Sellers RD, Amplatz K, Lillehei CW. Renal arteriography during extracorporeal circulation in dogs, with a preliminary report upon the effects of low molecular weight dextran. J Thorac Cardiovasc Surg 1961; 41: 252–62.PubMedGoogle Scholar
  113. 114.
    Moghissi K, Machell ES, Munday KA. Changes in renal blood flow and PAH extraction during extracorporeal circulation of short and long duration. Experimental study in dogs. Cardiovasc Res 1969; 3: 37–44.PubMedCrossRefGoogle Scholar
  114. 115.
    Hickey PR, Buckley MJ, Philbin DM. Pulsatile and nonpulsatile cardiopulmonary bypass: review of a counterproductive controversy. Ann Thorac Surg 1983; 36: 720–37.PubMedCrossRefGoogle Scholar
  115. 116.
    Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventicular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation 1991; 84: M236–44.Google Scholar
  116. 117.
    Andersson LG, Ekroth R, Bratteby LE, Hallhagen S, Wesslen O. Acute renal failure after coronary surgery-a study of incidence and risk factors in 2009 consecutive patients. Thorac Cardiovasc Surg 1993; 41: 237–41.PubMedCrossRefGoogle Scholar
  117. 118.
    Zanardo G, Michielon P, Paccagnella A, Rosi P, Calo M, Salandin V, DaRos A, Michieletto F, Simini G. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 1994; 107: 1489–95.PubMedGoogle Scholar
  118. 119.
    Corwin HL, Sprague SM, DeLaria GA, Norusis MJ. Acute renal failure associated with cardiac operations. A case-control study. J Thorac Cardiovasc Surg 1989; 98: 1107–12.PubMedGoogle Scholar
  119. 120.
    Lange HW, Aeppli DM, Brown DC. Survival of patients with acute renal failure requiring dialysis after open heart surgery: early prognostic indicators. Am Heart J 1987; 113: 1138–43.PubMedCrossRefGoogle Scholar
  120. 121.
    Alfieri A, Kolter MN. Noncardiac complications of open-heart surgery. Am Heart J 1990; 119: 149–58.PubMedCrossRefGoogle Scholar
  121. 122.
    Bhat JG, Gluck ML, Lowenstein J, Baldwin DS. Acute renal failure after open heart surgery. Aim Intern Med 1976; 84: 677–82.CrossRefGoogle Scholar
  122. 123.
    Andersen LW, Landow L, Baek L, Jansen E, Baker S. Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 1993; 21: 210–7.PubMedCrossRefGoogle Scholar
  123. 124.
    Aranha GV, Pickleman J, Pifarre R, Scanlon PJ, Gunnar RM. The reasons for gastrointestinal consultation after cardiac surgery. Am Surg 1984; 50: 301–4.PubMedGoogle Scholar
  124. 125.
    Tsiotos GG, Mullany CJ, Zietlow S, van Heerden JA. Abdominal complications following cardiac surgery. Am J Surg 1994; 167: 553–7.PubMedCrossRefGoogle Scholar
  125. 126.
    Christenson JT, Schmuziger M, Maurice J, Simonet F, Velebit V. Gastrointestinal complications after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994; 108: 899–906.PubMedGoogle Scholar
  126. 127.
    Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, Peters S, Rutledge F, Griffith L, McLellan A, Wood G, Kirby A. A comparison of sucrafate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 1998; 338: 791–7.PubMedCrossRefGoogle Scholar
  127. 128.
    Wang MJ, Chao A, Huang CH, Tsai CH, Lin FY, Wang SS, Liu CC, Chu SH. Hyperbilirubinemia after cardiac operation. Incidence, risk factors and clinical significance. J Thorac Cardiovasc Surg 1994; 108: 429–36.PubMedGoogle Scholar
  128. 129.
    Tremolada F, Loreggian M, Antona C, Girillo F, Norenta F, Realdi G. Blood-transmitted and clotting-factor-transmitted non-A, non-B hepatitis. Clinical differences and evolution. J Clin Gastroenterol 1998; 10: 413–8.CrossRefGoogle Scholar
  129. 130.
    Rattner DW, Gu ZY, Vlahakes GJ, Warshaw AL. Hyperamylasemia after cardiac surgery. Incidence, significance, and management. Ann Thorac Surg 1989; 209: 279–83.CrossRefGoogle Scholar
  130. 131.
    Haas GS, Warshaw AL, Daggett WM, Aretz HT. Acute pancreatitis after cardiopulmonary bypass. Am J Surg 1985; 149: 508–15.PubMedCrossRefGoogle Scholar
  131. 132.
    Aglio LS, Stanford GG, Maddi R, Boyd JL 3rd, Nussbaum S, Chemow B. Hypomagnesemia is common following cardiac surgery. J Cardiothorac Vasc Anesth 1991; 5: 201–8.PubMedCrossRefGoogle Scholar
  132. 133.
    Prielipp RC, Zaloga GP, Butterworth JF 4th, Robertie PG, Dudas LM, Black KW, Royster RL. Magnesium inhibits the hypertensive but not the cardiotonic actions of low-dose epinephrine. Anesthesiology 1991; 74: 973–9.PubMedCrossRefGoogle Scholar
  133. 134.
    Frater RW, Oka Y, Kadish A, Chilukuri S, Becker RM. Diabetes and coronary artery surgery. Mt Sinai J Med 1982; 49: 237–40.PubMedGoogle Scholar
  134. 135.
    Seki S. Clinical features of hyperosmolar hyperglycemic nonketotic diabetic coma associated with cardiac operations. J Thorac Cardiovasc Surg 1986; 91: 867–73.PubMedGoogle Scholar
  135. 136.
    George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986; 78: 340–8.PubMedCrossRefGoogle Scholar
  136. 137.
    Harker LA, Malpass TW, Branson HE, Hessel EA 2d, Slichter SJ. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. Blood 1980; 56: 824–34.PubMedGoogle Scholar
  137. 138.
    Valeri CR, Feingold H, Cassidy G, Ragno G, Khuri S, Altschule MD. Hypothermia-induced reversible platelet dysfunction. Ann Surg 1987; 205: 175–81.PubMedCrossRefGoogle Scholar
  138. 139.
    Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990; 76: 1680–97.PubMedGoogle Scholar
  139. 140.
    Brieger DB, Mak KH, Kottke-Marchant K, Topol EJ. Heparin-induced thrombocytopenia. J Am Coll Cardiol 1998; 31: 1449–59.PubMedCrossRefGoogle Scholar
  140. 141.
    Shorten GD, Comunale ME. Heparin-induced thrombocytopenia. J Cardiothorac Vasc Anesth 1996; 10: 521–30.PubMedCrossRefGoogle Scholar
  141. 142.
    Kollef MH, Sharpless L, Vlasnik J, Pasque C, Murphy D, Fraser VJ. The impact of nosocomial infections on patient outcome following cardiac surgery. Chest 1997; 112: 666–75.PubMedCrossRefGoogle Scholar
  142. 143.
    Ottino G, DePaulis R, Pansini S, Rocca G, Tallone MV, Comoglio C, Costa P, Orzan F, Morea M. Major sternal wound infection after open-heart surgery: a multivariate analysis of risk factors in 2,579 consecutive operative procedures. Ann Thorac Surg 1987; 44: 173–9.PubMedCrossRefGoogle Scholar
  143. 144.
    Culliford AT, Cunningham JN Jr, Zeff RH, Ison OW, Teiko P, Spencer FC. Sternal and costochondral infections following open-heart surgery. A review of 2,594 cases.J Thorac Cardiovasc Surg 1976; 72: 714–26.Google Scholar
  144. 145.
    Gottlieb LJ, Pielet RW, Karp RB, Krieger LM, Smith DJ Jr, Deeb GM. Rigid internal fixation of the sternum in postoperative mediastinitis. Arch Surg 1994; 129: 489–93.PubMedCrossRefGoogle Scholar
  145. 146.
    Demmy TL, Park SB, Liebler GA, Burkholder JA, Maher TD, Benckart DH, Magovern GJ Jr, Magovem GJ Sr. Recent experience with major sternal wound complications. Ann Thorac Surg 1990; 49: 458–62.PubMedCrossRefGoogle Scholar
  146. 147.
    Cosgrove DM, Lytle BW, Loop FD, Taylor PC, Stewart RW, Gill CC, Golding LA, Goormastic M. Does bilateral internal mammary artery grafting increase surgical risk? J Thorac Cardiovasc Surg 1988; 95: 850–6.PubMedGoogle Scholar
  147. 148.
    Gottlieb LJ, Beahm EK, Krizek TJ, Karp RB. Approaches to sternal wound infections. Adv Card Surg 1996; 7: 147–62.PubMedGoogle Scholar
  148. 149.
    Verkkala K. Occurrence of and microbiological findings in postoperative infections following open-heart surgery. Effect on mortality and hospital stay. Ann Clin Res 1987; 19: 170–7.PubMedGoogle Scholar
  149. 150.
    Kay HR, Goodman LR, Teplick SK, Mundth ED. Use of computed tomography to assess mediastinal complications after median sternotomy. Ann Thorac Surg 1983; 36: 706–14.PubMedCrossRefGoogle Scholar
  150. 151.
    DeLaria GA, Hunter JA, Goldin MD, Serry C, Javid H, Najafi H. Leg wound complications associated with coronary revascularization. J Thorac Cardiovasc Surg 1981; 81: 403–7.PubMedGoogle Scholar
  151. 152.
    Loop FD, Cosgrove DM, Lytle BW, Thurer RL, Simpfendorfer C, Taylor PC, Proudfit WL. An 11 year evolution of coronary arterial bypass grafting (1968–1978). Ann Surg 1979; 190: 444–55.PubMedCrossRefGoogle Scholar
  152. 153.
    Gardner TJ, Hofneffer PJ, Manolio TA, Pearson TA, Gott VL, Baumgartner WA, Borkon AM, Watkins L Jr, Reitz BA. Stroke following coronary artery bypass grafting: a ten year study. Ann Thor ac Surg 1985; 40: 574–81.CrossRefGoogle Scholar
  153. 154.
    Taylor GJ, Malik SA, Colliver JA, Dove JT, Moses HW, Mikell FL, Batchelder JE, Schneider JA, Wellons HA. Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. Am J Cardiol 1987; 60: 905–7.PubMedCrossRefGoogle Scholar
  154. 155.
    Tuman KJ, McCarthy RJ, Najafi H, Ivankovich AD. Differential effects of advanced age on neurologic and cardiac risks of coronary artery operations. J Thorac Cardiovasc Surg 1992; 104: 1510–7.PubMedGoogle Scholar
  155. 156.
    Lynn GM, Stefanko K, Reed JF 3d, Gee W, Nicholas G. Risk factors for stroke after coronary artery bypass. J Thorac Cardiovasc Surg 1992; 104: 1518–23.PubMedGoogle Scholar
  156. 157.
    Furlan AJ, Breuer AC. Central nervous system complications of open-heart surgery. Stroke 1984; 15: 912–5.PubMedCrossRefGoogle Scholar
  157. 158.
    Smith LW, Dimsdale JE. Postcardiotomy delirium: conclusions after 25 years? Am J Psychiatry 1989; 146: 452–8.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Ross F. DiMarcoJr.
    • 1
  1. 1.Mercy Hospital of PittsburghCarnegieUSA

Personalised recommendations